TY - JOUR
T1 - Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E
T2 - A novel neonatal phenotype similar to peroxisomal biogenesis disorders
AU - Corzo, Deyanira
AU - Gibson, William
AU - Johnson, Kisha
AU - Mitchell, Grant
AU - LePage, Guy
AU - Cox, Gerald F.
AU - Casey, Robin
AU - Zeiss, Carolyn
AU - Tyson, Heidi
AU - Cutting, Garry R.
AU - Raymond, Gerald V.
AU - Smith, Kirby D.
AU - Watkins, Paul A.
AU - Moser, Ann B.
AU - Moser, Hugo W.
AU - Steinberg, Steven J.
PY - 2002
Y1 - 2002
N2 - X-linked adrenoleukodystrophy (X-ALD) results from mutations in ABCD1. ABCD1 resides on Xq28 and encodes an integral peroxisomal membrane protein (ALD protein [ALDP]) that is of unknown function and that belongs to the ATP-binding cassette-transporter superfamily. Individuals with ABCD1 mutations accumulate very-long-chain fatty acids (VLCFA) (carbon length >22). Childhood cerebral X-ALD is the most devastating form of the disease. These children have the earliest onset (age 7.2 ± 1.7 years) among the clinical phenotypes for ABCD1 mutations, but onset does not occur at <3 years of age. Individuals with either peroxisomal biogenesis disorders (PBD) or single-enzyme deficiencies (SED) in the peroxisomal β-oxidation pathway - disorders such as acyl CoA oxidase deficiency and bifunctional protein deficiency - also accumulate VLCFA, but they present during the neonatal period. Until now, it has been possible to distinguish unequivocally between individuals with these autosomal recessively inherited syndromes and individuals with ABCD1 mutations, on the basis of the clinical presentation and measurement of other biochemical markers. We have identified three newborn boys who had clinical symptoms and initial biochemical results consistent with PBD or SED. In further study, however, we showed that they lacked ALDP, and we identified deletions that extended into the promoter region of ABCD1 and the neighboring gene, DXS1357E. Mutations in DXS1357E and the ABCD1 promoter region have not been described previously. We propose that the term "contiguous ABCD1 DXS1357E deletion syndrome" (CADDS) be used to identify this new contiguous-gene syndrome. The three patients with CADDS who are described here have important implications for genetic counseling, because individuals with CADDS may previously have been misdiagnosed as having an autosomal recessive PBD or SED.
AB - X-linked adrenoleukodystrophy (X-ALD) results from mutations in ABCD1. ABCD1 resides on Xq28 and encodes an integral peroxisomal membrane protein (ALD protein [ALDP]) that is of unknown function and that belongs to the ATP-binding cassette-transporter superfamily. Individuals with ABCD1 mutations accumulate very-long-chain fatty acids (VLCFA) (carbon length >22). Childhood cerebral X-ALD is the most devastating form of the disease. These children have the earliest onset (age 7.2 ± 1.7 years) among the clinical phenotypes for ABCD1 mutations, but onset does not occur at <3 years of age. Individuals with either peroxisomal biogenesis disorders (PBD) or single-enzyme deficiencies (SED) in the peroxisomal β-oxidation pathway - disorders such as acyl CoA oxidase deficiency and bifunctional protein deficiency - also accumulate VLCFA, but they present during the neonatal period. Until now, it has been possible to distinguish unequivocally between individuals with these autosomal recessively inherited syndromes and individuals with ABCD1 mutations, on the basis of the clinical presentation and measurement of other biochemical markers. We have identified three newborn boys who had clinical symptoms and initial biochemical results consistent with PBD or SED. In further study, however, we showed that they lacked ALDP, and we identified deletions that extended into the promoter region of ABCD1 and the neighboring gene, DXS1357E. Mutations in DXS1357E and the ABCD1 promoter region have not been described previously. We propose that the term "contiguous ABCD1 DXS1357E deletion syndrome" (CADDS) be used to identify this new contiguous-gene syndrome. The three patients with CADDS who are described here have important implications for genetic counseling, because individuals with CADDS may previously have been misdiagnosed as having an autosomal recessive PBD or SED.
UR - http://www.scopus.com/inward/record.url?scp=18344362785&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=18344362785&partnerID=8YFLogxK
U2 - 10.1086/340849
DO - 10.1086/340849
M3 - Article
C2 - 11992258
AN - SCOPUS:18344362785
SN - 0002-9297
VL - 70
SP - 1520
EP - 1531
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 6
ER -